Andre Veillette
Overview
Explore the profile of Andre Veillette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
3387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang J, Song H, Li S, Lam S, Ping J, Yang M, et al.
Adv Sci (Weinh)
. 2024 Aug;
11(39):e2402693.
PMID: 39136057
Infection by bacteria leads to tissue damage and inflammation, which need to be tightly controlled by host mechanisms to avoid deleterious consequences. It is previously reported that TMEM16F, a calcium-activated...
2.
Li R, Galindo C, Davidson D, Guo H, Zhong M, Qian J, et al.
Cell Rep
. 2024 Feb;
43(3):113800.
PMID: 38386559
Infection of mice by mouse cytomegalovirus (MCMV) triggers activation and expansion of Ly49H natural killer (NK) cells, which are virus specific and considered to be "adaptive" or "memory" NK cells....
3.
Tang Z, Zhong M, Qian J, Galindo C, Davidson D, Li J, et al.
Nat Immunol
. 2023 Nov;
24(12):2032-2041.
PMID: 37945822
Cancer cells often overexpress CD47, which triggers the inhibitory receptor SIRPα expressed on macrophages, to elude phagocytosis and antitumor immunity. Pharmacological blockade of CD47 or SIRPα is showing promise as...
4.
Wu N, Veillette A
Cell Mol Immunol
. 2023 Apr;
20(9):1081-1083.
PMID: 37012395
No abstract available.
5.
Tang Z, Veillette A
Nat Nanotechnol
. 2022 Nov;
17(12):1243-1244.
PMID: 36357791
No abstract available.
6.
Li B, Lu Y, Zhong M, Qian J, Li R, Davidson D, et al.
Sci Immunol
. 2022 Aug;
7(74):eabn6373.
PMID: 35930657
CD2 is largely described to promote T cell activation when engaged by its ligands, CD48 in mice and CD58 in humans, that are present on antigen-presenting cells (APCs). However, both...
7.
Hasim M, Marotel M, Hodgins J, Vulpis E, Makinson O, Asif S, et al.
Sci Adv
. 2022 Apr;
8(15):eabj3286.
PMID: 35417234
Trogocytosis modulates immune responses, with still unclear underlying molecular mechanisms. Using leukemia mouse models, we found that lymphocytes perform trogocytosis at high rates with tumor cells. While performing trogocytosis, both...
8.
Tang Z, Davidson D, Li R, Zhong M, Qian J, Chen J, et al.
Cell Rep
. 2021 Dec;
37(11):110111.
PMID: 34910922
Blockade of the inhibitory checkpoint SIRPα-CD47 promotes phagocytosis of cancer cells by macrophages and is a promising avenue in anti-cancer therapy. Productive phagocytosis is strictly predicated on co-engagement of pro-phagocytic...
9.
Gutierrez-Guerrero A, Mancilla-Herrera I, Maravillas-Montero J, Martinez-Duncker I, Veillette A, Cruz-Munoz M
Eur J Immunol
. 2021 Oct;
52(1):62-74.
PMID: 34693521
NK cells play an important role in immunity by recognizing and eliminating cells undergoing infection or malignant transformation. This role is dependent on the ability of NK cells to lyse...
10.
Veillette A
Sci Signal
. 2021 May;
14(684).
PMID: 34035144
Cell-bound ligands are often viewed as moving passively in response to displacement of their cognate receptors. Verron provide an example of the distribution of ligands influencing the functional outcome of...